secwatch.observer — SEC 8-K summary
======================================

Issuer:     ATOSSA THERAPEUTICS, INC. (ATOS)
CIK:        0001488039
Form:       8-K
Filed at:   2025-05-12T23:59:59+00:00
Accession:  0000950170-25-068333
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Atossa stockholders elect directors, ratify auditor, approve say-on-pay at 2025 annual meeting
--------------------------------------------------------------------------------

- Class I directors Steven C. Quay (28.4M for, 4.2M withheld) and Jonathan F. Finn (30.2M for, 2.4M withheld) elected.
- Ratification of Ernst & Young as auditor passed with 55.8M for, 6.7M against, 1.4M abstain.
- Non-binding advisory vote on executive compensation approved with 25.6M for, 6.5M against, 0.5M abstain.
- Stockholders selected one-year frequency for future say-on-pay votes (29.3M votes for 1 year).
- Record date March 20, 2025; 129,170,004 shares entitled to vote.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1488039/000095017025068333/0000950170-25-068333-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1488039/000095017025068333/atos-20250508.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-068333

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer